You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the European Union Drugs Agency (EUDA).

Figure INF-25 Estimated access to highly active anti retroviral treatment (HAART) in WHO European Region, end of 2004

Figure INF-25

Source:

WHO Regional Office for Europe Health for All Database www.euro.who.int/hfadb (accessed 8 March 2005).